<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01217151</url>
  </required_header>
  <id_info>
    <org_study_id>GDT NICOM</org_study_id>
    <nct_id>NCT01217151</nct_id>
  </id_info>
  <brief_title>Perioperative Hemodynamic Optimization Using the NICOM Device</brief_title>
  <official_title>Perioperative Hemodynamic Goal-directed Optimization Using the Noninvasive NICOM™ Monitoring Device in Major Abdominal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario La Paz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital of the Nuestra Señora de Candelaria</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital del Río Hortega</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital General de Ciudad Real</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Valencia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Carmel Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitario La Paz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the last years, there is a growing interest in the improvement of prognosis and shortening
      of hospital length of stay in high-risk surgical patients. Several evidence-based protocols
      (&quot;fast-track&quot; surgery) have been developed and implemented in some hospitals for this
      purpose. Cardiovascular optimization through the so-called &quot;goal-directed therapy&quot; (GDT) is a
      key element in these protocols. Previous studies in the literature use invasive monitors to
      assess hemodynamics. The NICOM ™ is a non-invasive monitor validated in several clinical
      scenarios. The aim of the present randomized, international, multi-center, open-label
      clinical trial is to use a GDT protocol (including colloid boluses and vasoactive drug
      infusion) based on data obtained from the NICOM™ device (cardiac index and mean arterial
      pressure) to test the hypothesis that GDT is superior to standard practice in terms of
      reduction in the incidence of perioperative complications and length of hospital stay in
      high-risk major abdominal surgery patients (requiring ICU surveillance for, at least, 24
      hours). As secondary objectives, time to first flatus, wound infection, anastomotic leaks and
      mortality will be analysed. All patients will be followed from the day of surgery up to
      hospital discharge (determined by a specialist surgeon not involved in the study) or death.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease in hospital length of stay</measure>
    <time_frame>Three months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to peristalsis recovery</measure>
    <time_frame>Three weeks</time_frame>
    <description>Peristalsis shall be assessed by first flatus after abdominal surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of wound infection</measure>
    <time_frame>Three weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of anastomotic leaks</measure>
    <time_frame>Three weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any cause mortality</measure>
    <time_frame>Three months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">142</enrollment>
  <condition>Major Abdominal Surgery</condition>
  <arm_group>
    <arm_group_label>Usual treatment</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The hemodynamic management will be performed according to the institution's standard of care, using fluids at the discretion of the anesthesiologist and the ICU specialist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NICOM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>For volume replacement, crystalloids will be used following the standard procedure according to the anesthesiologist or ICU specialist. Mean arterial pressure and cardiac index will be assessed every 5 minutes, and a volume bolus (250 mL colloid in 10 minutes) will be used to achieve a:
Mean arterial pressure ≥ 65 mmHg (intra and postoperatively), AND
Cardiac index ≥ 2.5 L/min/m2 (intra and postoperatively).
If these cardiovascular parameters are not met after the first colloid infusion, a supplementary bolus will be added. In case of not achieving the target, additional colloid boluses and/or pharmacologic support (norepinephrine in case of persistent hypotension, dobutamine in case of low cardiac output) will be provided according to the protocol</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hemodynamic monitoring</intervention_name>
    <description>Hemodynamic monitoring based on the NICOM device</description>
    <arm_group_label>NICOM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual treatment</intervention_name>
    <description>Hemodynamic monitoring based on common practice</description>
    <arm_group_label>Usual treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients scheduled for:

          -  Open colorectal surgery: hemicolectomy, pancolectomy, abdomino-perineal resection.

          -  Gastrectomy.

          -  Small bowel resection.

          -  Signed written informed consent.

        Exclusion Criteria:

          -  Less than 18 years old.

          -  Laparoscopic procedure.

          -  Emergency surgery.

          -  Intra-abdominal infection.

          -  Patients not requiring ICU admission (patients should stay for at least the first day
             at the ICU).

          -  Life expectancy lower than 60 days.

          -  Disseminated malignancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Pestaña, M.D. Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario La Paz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Carmel Medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>34362</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General</name>
      <address>
        <city>Ciudad Real</city>
        <zip>13005</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Nuestra Señora de la Candelaria</name>
      <address>
        <city>Santa Cruz de Tenerife</city>
        <zip>38010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Río Hortega</name>
      <address>
        <city>Valladolid</city>
        <zip>47009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Squara P, Rotcajg D, Denjean D, Estagnasie P, Brusset A. Comparison of monitoring performance of Bioreactance vs. pulse contour during lung recruitment maneuvers. Crit Care. 2009;13(4):R125. doi: 10.1186/cc7981. Epub 2009 Jul 28.</citation>
    <PMID>19638227</PMID>
  </reference>
  <reference>
    <citation>Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED. Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised, controlled trial [ISRCTN38797445]. Crit Care. 2005;9(6):R687-93. Epub 2005 Nov 8.</citation>
    <PMID>16356219</PMID>
  </reference>
  <reference>
    <citation>Lopes MR, Oliveira MA, Pereira VO, Lemos IP, Auler JO Jr, Michard F. Goal-directed fluid management based on pulse pressure variation monitoring during high-risk surgery: a pilot randomized controlled trial. Crit Care. 2007;11(5):R100.</citation>
    <PMID>17822565</PMID>
  </reference>
  <reference>
    <citation>Benes J, Chytra I, Altmann P, Hluchy M, Kasal E, Svitak R, Pradl R, Stepan M. Intraoperative fluid optimization using stroke volume variation in high risk surgical patients: results of prospective randomized study. Crit Care. 2010;14(3):R118. doi: 10.1186/cc9070. Epub 2010 Jun 16.</citation>
    <PMID>20553586</PMID>
  </reference>
  <reference>
    <citation>Gan TJ, Soppitt A, Maroof M, el-Moalem H, Robertson KM, Moretti E, Dwane P, Glass PS. Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. Anesthesiology. 2002 Oct;97(4):820-6.</citation>
    <PMID>12357146</PMID>
  </reference>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2010</study_first_submitted>
  <study_first_submitted_qc>October 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2010</study_first_posted>
  <last_update_submitted>November 19, 2012</last_update_submitted>
  <last_update_submitted_qc>November 19, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 20, 2012</last_update_posted>
  <responsible_party>
    <name_title>David Pestaña</name_title>
    <organization>Hospital Universitario La Paz</organization>
  </responsible_party>
  <keyword>Hemodynamic Monitoring</keyword>
  <keyword>Goal-Directed Therapy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

